Judith Wienke Selected Research

Judith Wienke Research Topics

6	Neoplasms (Cancer) 12/2023 - 01/2021
5	Neuroblastoma 12/2023 - 01/2021
5	Dermatomyositis (Dermatopolymyositis) 01/2022 - 01/2019
3	Inflammation (Inflammations) 01/2021 - 01/2018
3	Autoimmune Diseases (Autoimmune Disease) 01/2021 - 12/2018
3	Myositis (Idiopathic Inflammatory Myopathies) 01/2020 - 01/2018
1	Melanoma (Melanoma, Malignant) 12/2022
1	Diffuse Intrinsic Pontine Glioma 08/2021
1	Eosinophilic Fasciitis 01/2021
1	Localized Scleroderma (Morphea) 01/2021
1	Vascular Diseases (Vascular Disease) 12/2018
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 12/2018
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 12/2018
1	Necrosis 12/2018

5	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2018
4	InterferonsIBA 01/2022 - 01/2018
2	dinutuximabIBA 08/2021 - 01/2021
2	AutoantibodiesIBA 01/2021 - 01/2018
2	Type II Tumor Necrosis Factor ReceptorsIBA 01/2021 - 12/2018
1	RNA (Ribonucleic Acid)IBA 12/2023
1	Caspase 3 (Caspase-3)IBA 01/2023
1	Serum-Free Culture MediaIBA 01/2023
1	entinostat (MS 275)IBA 12/2022
1	AntigensIBA 12/2022
1	Sialic Acid Binding Ig-like Lectin 1IBA 01/2022
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 09/2021
1	dipinacoline glutamateIBA 08/2021
1	Monoclonal AntibodiesIBA 08/2021
1	Interleukin-18 (Interleukin 18)IBA 01/2021
1	Galectin 1 (LGALS1)IBA 01/2021
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021
1	AngiopoietinsIBA 01/2021
1	TIE Receptors (TIE Receptor Tyrosine Kinases)IBA 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	FetuinsIBA 01/2021
1	Fibronectins (Fibronectin)IBA 01/2021
1	Blood Proteins (Serum Proteins)IBA 01/2021
1	5'-Nucleotidase (5' Nucleotidase)IBA 01/2021
1	Immune Checkpoint ProteinsIBA 01/2021
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 01/2021
1	Thrombospondin 1IBA 01/2021
1	N 30IBA 01/2020
1	AntibodiesIBA 01/2020
1	Proteins (Proteins, Gene)FDA Link 01/2019